Clinical Trial

Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

Name: Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer — clinical trial record (NCT06745219)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated December 20, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

Exploring and evaluating the efficacy of herombopag in preventing thrombocytopenia due to radiotherapy for cervical cancer

Trial Details

NCT Number	NCT06745219
Lead Sponsor	Peking University Cancer Hospital & Institute
Conditions	Thrombopenia, Cervical Cancer, Radiotherapy Side Effect, Chemotherapeutic Toxicity
Enrollment	30 participants
Start Date	2025-01-01
Primary Completion	2025-06-30 (estimated)
Study Completion	2025-07-30 (estimated)
Updated on ClinicalTrials.gov	2024-12-20